CELF1 (CUGBP Elav-Like Family Member 1) is an RNA-binding protein encoded by the CELF1 gene located on chromosome 11p11.2. It is also known as CUGBP1 (CUG-binding protein 1) and is a member of the CELF/BRUNOL family of RNA-binding proteins. CELF1 plays crucial roles in post-transcriptional regulation of gene expression, including alternative splicing, mRNA stability, and translation control.
CELF1 dysfunction is implicated in several neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS), myotonic dystrophy type 1, and Alzheimer's disease.[1]
The protein encoded by CELF1 is CELF1 Protein.[2]
CELF1 is a multifunctional RNA-binding protein that regulates gene expression at multiple levels. The protein contains three RNA recognition motifs (RRMs) that mediate sequence-specific binding to target mRNAs. CELF1 recognizes GU-rich elements (GREs) and CUG repeats in RNA, making it particularly relevant to diseases involving repeat expansions.
Through its regulatory functions, CELF1 influences:
- Neuronal development and function
- Synaptic plasticity
- Muscle fiber excitability
- Stress responses
| Property |
Value |
| Gene Symbol |
CELF1 |
| Full Name |
CUGBP Elav-Like Family Member 1 |
| Chromosome |
11p11.2 |
| NCBI Gene ID |
10658 |
| OMIM |
601998 |
| Ensembl ID |
ENSG00000131095 |
| UniProt ID |
Q9UQF0 |
¶ Protein Structure and Function
¶ Domain Architecture
CELF1 contains:
- Three RNA Recognition Motifs (RRMs): RRM1, RRM2, and RRM3
- N-terminal region: Involved in protein-protein interactions
- C-terminal region: Regulatory functions
CELF1 binds to:
- GU-rich elements (GREs): Common in transcripts regulated during stress
- CUG repeats: Pathogenic in myotonic dystrophy type 1
- AU-rich elements (AREs): Found in unstable mRNAs
Alternative Splicing:
CELF1 regulates the splicing of numerous neuronal and muscle-specific exons. It can either promote or repress exon inclusion depending on binding site location and context.
Key splicing targets include:
- Tau (MAPT) exon 10 (regulated in Alzheimer's)
- NMDA receptor subunits
- Calcium channel transcripts
- Autophagy-related transcripts
mRNA Stability:
CELF1 affects mRNA half-life by binding to AREs and GREs, generally destabilizing target transcripts.
Translation Control:
CELF1 modulates translation through:
- Direct interaction with translation initiation factors
- Regulation of ribosomal protein synthesis
- Stress granule formation
CELF1 is widely expressed in the nervous system:
- Cerebral cortex: Neurons and glia
- Hippocampus: CA regions and dentate gyrus
- Spinal cord: Motor neurons (particularly relevant to ALS)
- Cerebellum: Purkinje cells and granule cells
- Brainstem: Various neuronal populations
- Nucleus: Splicing regulation
- Cytoplasm: Translation control
- Stress granules: Formed during cellular stress
- Synaptic terminals: Local translation regulation
CELF1 is a known ALS gene:
- Mutations: D262N, E191K, and others cause familial ALS
- Mechanism: Altered RNA splicing of survival motor neuron (SMN) transcripts
- Pathogenesis: Toxic gain-of-function and disrupted RNA processing
- Related proteins: TDP-43 (TARDBP), FUS, SMN1
CELF1 dysregulation is central to DM1 pathogenesis:
- Trigger: CTG repeat expansion in DMPK gene
- Mechanism: Mutant DMPK RNA sequesters CELF1
- Consequence: Loss of CELF1 function on normal targets
- Phenotype: Muscle weakness, myotonia, cardiac conduction defects
CELF1 contributes to AD pathogenesis:
- Tau splicing: Regulates tau exon 10 inclusion
- Alternative splicing: Affects amyloid precursor protein (APP) processing
- Stress responses: Involved in cellular stress pathways
- Altered expression in PD brain
- May affect alpha-synuclein RNA processing
- Modulates stress granule dynamics
- Risk variants affect cardiac ion channel splicing
- Relevant to both DM1-associated and isolated cardiac disease
In diseases with repeat expansions:
- Pathogenic RNA repeats sequester CELF1
- Normal RNA processing is disrupted
- Loss-of-function on physiological targets
Key targets affected:
- Tau (MAPT): Mis-splicing leads to 3R/4R tau imbalance
- SMN2: Affects motor neuron survival
- Neuronal ion channels: Altered excitability
CELF1 participates in:
- Stress granule formation
- Translation shutoff during stress
- Cell survival decisions
- Antisense oligonucleotides (ASOs) targeting CELF1
- Small molecules modulating CELF1-RNA interactions
- ASOs targeting toxic repeat RNAs
- AAV-delivered CELF1 modulators
- CRISPR-based approaches to correct splicing
¶ Repurposing Candidates
- Sodium channel modulators (for myotonia)
- Stress granule inhibitors
- Patient-derived iPSC neurons
- Motor neuron cultures
- Muscle cell models
- Celf1 knockout mice
- Transgenic CELF1 mutant mice
- DM1 mouse models
- CLIP-seq for RNA targets
- Proteomic analysis of CELF1 complexes
¶ Diagnostic and Clinical Relevance
- CELF1 sequencing for ALS diagnosis
- Family testing for at-risk individuals
- CELF1 splicing events as disease biomarkers
- CSF analysis for CELF1-related changes
- Specific mutations correlate with disease progression
- Splicing patterns predict outcomes
The study of Celf1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- CELF1 in ALS - Nature Neuroscience
- CELF1 Protein - UniProt
- CELF1 and Myotonic Dystrophy - Brain Research
- RNA Binding Proteins in Neurodegeneration - Nature Reviews Neuroscience
- CELF1 in Alzheimer's Disease - Acta Neuropathologica